Literature DB >> 28296610

Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Disease.

Gregg W Stone1, Joseph F Sabik2, Patrick W Serruys3, A Pieter Kappetein4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28296610     DOI： 10.1056/NEJMc1701177

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

Review 1.  Neurological Complications of Cardiological Interventions.

Authors:  Amir Shaban; Enrique C Leira
Journal:  Curr Neurol Neurosci Rep       Date:  2019-02-09       Impact factor: 5.081

2.  Over-expansion of drug-eluting stents in patients with left main coronary artery disease: An in vivo study.

Authors:  Yicong Ye; Hao Qian; Ming Yang; Xueqing Zhu; Tianpeng Gan; Shuyang Zhang; Yong Zeng
Journal:  J Int Med Res       Date:  2017-06-12       Impact factor: 1.671

3.  Beyond the ISCHEMIA Trial: Revascularization for Stable Ischemic Heart Disease in Patients With High-Risk Coronary Anatomical Features.

Authors:  Brian A Bergmark; David A Morrow
Journal:  J Am Heart Assoc       Date:  2020-12-19       Impact factor: 5.501

4.  Outcomes of Unprotected Left Main Percutaneous Coronary Intervention: A Single-Centre Experience.

Authors:  Nooraldaem Yousif; Babu Thevan; Suddharsan Subbramaniyam; Mohamed Alkhayat; Shereen Alshaikh; Sadananda Shivappa; Haitham Amin; Mary Tareif; Fuad Abdulqader; Husam A Noor
Journal:  Heart Views       Date:  2021-04-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.